We evaluated strategies for postmarket surveillance of medical devices in the United States, European Union, Japan, and China.
No takes yet. Share an insight, caveat, or question.
Kramer et al. (2013) studied this question.
Synapse has enriched 2 closely related papers on similar clinical questions. Consider them for comparative context: